Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study

[1]  Janet Diaz,et al.  A clinical case definition of post-COVID-19 condition by a Delphi consensus , 2021, The Lancet Infectious Diseases.

[2]  D. Francisci,et al.  Low Brachial Artery Flow-Mediated Dilation Predicts Worse Prognosis in Hospitalized Patients with COVID-19 , 2021, Journal of clinical medicine.

[3]  Driton Vela,et al.  Efficacy and safety of tocilizumab versus standard care/placebo in patients with COVID‐19; a systematic review and meta‐analysis of randomized clinical trials , 2021, British journal of clinical pharmacology.

[4]  C. Tsioufis,et al.  The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis. , 2021, Current medicinal chemistry.

[5]  M. Brodmann,et al.  Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection—A Cross-Sectional Study , 2021, Frontiers in Cardiovascular Medicine.

[6]  E. Ciolac,et al.  Determinants of endothelial dysfunction in noncritically ill hospitalized COVID‐19 patients: A cross‐sectional study , 2021, Obesity.

[7]  D. Tousoulis,et al.  Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA) , 2021, Cardiovascular research.

[8]  I. Andreadou,et al.  Association of COVID‐19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection , 2021, European journal of heart failure.

[9]  M. Maniscalco,et al.  Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study , 2021, Biomedicines.

[10]  P. Farrington,et al.  Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study , 2021, The Lancet.

[11]  R. Veazey,et al.  Endothelial cell infection and dysfunction, immune activation in severe COVID-19 , 2021, Theranostics.

[12]  C. Tsioufis,et al.  Inflammatory Mechanisms Contributing to Endothelial Dysfunction , 2021, Biomedicines.

[13]  M. Maniscalco,et al.  Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation , 2021, Biomedicines.

[14]  R. Arena,et al.  Endothelial function provides early prognostic information in patients with COVID-19: A cohort study , 2021, Respiratory Medicine.

[15]  D. Panagiotakos,et al.  Excess mortality in Greece during 2020: the role of COVID-19 and cardiovascular disease , 2021, Hellenic Journal of Cardiology.

[16]  Dave L Dixon,et al.  Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 , 2021, Nature Reviews Immunology.

[17]  O. Collange,et al.  Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection , 2021, Journal of clinical medicine.

[18]  Christopher M. Horvat,et al.  Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 - Preliminary report , 2021, medRxiv.

[19]  J. Pedrosa,et al.  Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia , 2021, Frontiers in Immunology.

[20]  D. Andaluz-Ojeda,et al.  MR‐proADM as marker of endotheliitis predicts COVID‐19 severity , 2021, European journal of clinical investigation.

[21]  R. Ferrari,et al.  Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients , 2020, Critical Care.

[22]  E. Zaggelidou,et al.  Impact of social containment measures on cardiovascular admissions and sudden cardiac death rates during Coronavirus Disease (COVID-19) outbreak in Greece , 2020, Hellenic Journal of Cardiology.

[23]  Ashutosh Kumar,et al.  Histopathological observations in COVID-19: a systematic review , 2020, Journal of Clinical Pathology.

[24]  C. Vlachopoulos,et al.  Hospital attendance and admission trends for cardiac diseases during the COVID-19 outbreak and lockdown in Greece , 2020, Public Health.

[25]  C. Weber,et al.  Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science , 2020, Cardiovascular research.

[26]  A. Rodríguez-Morales,et al.  A review of the main histopathological findings in coronavirus disease 2019 , 2020, Human Pathology.

[27]  D. Tousoulis,et al.  The impact of COVID-19 pandemic on adult cardiac surgery procedures , 2020, Hellenic Journal of Cardiology.

[28]  C. Tsioufis,et al.  The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the “Ariadne's thread” for the “labyrinth” of COVID-19 , 2020, Hellenic Journal of Cardiology.

[29]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[30]  D. Thijssen,et al.  Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. , 2019, European heart journal.

[31]  Yaiza Beatriz Molero-Díez,et al.  Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.

[32]  Jeroen J. Bax,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Circulation.

[33]  P. Libby,et al.  Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) , 2018, European heart journal.

[34]  Gurkirpal Singh,et al.  Interleukin 6 Inhibition and Coronary Artery Disease in a High‐Risk Population: A Prospective Community‐Based Clinical Study , 2017, Journal of the American Heart Association.

[35]  A. Papavassiliou,et al.  Flow-mediated dilation: is it just a research tool or a useful biomarker for cardiovascular prognosis. , 2015, International journal of cardiology.

[36]  N. Tangri,et al.  Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis. , 2014, European heart journal cardiovascular Imaging.

[37]  C. Stefanadis,et al.  Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques , 2005, Heart.

[38]  W. Muller.  Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. , 2003, Trends in immunology.

[39]  K. Miwa,et al.  Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. , 1997, Cardiovascular research.